A number of key technology patents involve the whole process of cell culture in vitro, such as cell extraction, preparation and inspection.
Headquartered in Huangcheng Street, its business scope covers first-and second-tier cities such as Guangzhou, Shenzhen, Shanghai, Nanjing, Chengdu, Qingdao, Wuxi, Zhengzhou and Changzhou.
Royal International is a leader, innovator and pioneer in the downstream application field of stem cell industry in China, and it is currently going public with the help of the impact of the national market.